M
M. Christopher Runken
Researcher at Research Triangle Park
Publications - 7
Citations - 13
M. Christopher Runken is an academic researcher from Research Triangle Park. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications receiving 12 citations.
Papers
More filters
Journal ArticleDOI
Impact of solifenacin on quality of life, medical care use, work productivity, and health utility in the elderly: an exploratory subgroup analysis.
Norman Zinner,Les Noe,Lawrence Rasouliyan,Thomas S. Marshall,M. Christopher Runken,Raafat Seifeldin +5 more
TL;DR: Overall, solifenacin was found to improve symptom bother, HRQoL, work productivity, activity participation, and reduced medical care resource utilization in these elderly subjects with OAB who continued to have urgency symptoms with tolterodine and were willing to try solifentacin.
Journal ArticleDOI
EE329 Early Albumin Infusion in Cirrhotic Patients with Spontaneous Bacterial Peritonitis (SBP) Is Associated with Reductions in Total Hospitalization Costs: A Cross-Sectional Study
TL;DR: In this paper , the authors examined the relationship between albumin infusion timing and total hospitalization cost among cirrhotic inpatients who developed SBP during hospitalization, and found that albumin administration in conjunction with antibiotics was beneficial for SBP management.
Journal ArticleDOI
MSR6 Assessing the Impact of Early Albumin Administration in Patients Requiring Intravascular Resuscitation: Application of Machine Learning Techniques to Electronic Health Record (EHR) Data
Elisabet Viayna,Thomas Ardiles,M. Christopher Runken,Ina Weimer,X. Zhang,Farah Pathan,Kunal Lodaya +6 more
TL;DR: In this article , the authors applied machine learning techniques to electronic health records data from patients with anemia and gastrointestinal bleeding, alcoholic liver disease, hepatic failure, acute pancreatitis, and nephrotic syndrome, to identify subpopulations that may benefit from early albumin administration.
Journal ArticleDOI
P57 Mapping Quality of Life - Alzheimer's Disease (QOL-AD) Scores to EQ-5D-5L Utilities in the Ambar Trial Population
Chelsea Simons,David Gómez-Ulloa,M. Christopher Runken,David P. Serrano,Brittany Barnes,Carlota Grifols,Miquel Barceló,Lauren Podger +7 more
TL;DR: The AMBAR phase 2b/3 trial (NCT01561053) as mentioned in this paper evaluated the efficacy and safety of plasma exchange with albumin replacement in mild-to-moderate Alzheimer's disease (AD) patients.
Journal ArticleDOI
EE260 Early Albumin Infusion May Reduce Intensive Care Unit (ICU) Cost in Cirrhotic Patients with Spontaneous Bacterial Peritonitis (SBP): A Cross-Sectional Study
TL;DR: In this article , the authors examined the relationship between early albumin infusion and ICU cost in a subgroup of cirrhotic patients who developed SBP during hospitalization, and found that albumin is recommended by the American Association for the Study of Liver Diseases as an adjuvant to antibiotics for the management of SBP.